By TechnologyMicroinjection · Embryonic Stem Cell (ESC) Injection · Nuclear Transfer (Cloning) · CRISPR/Cas9 and Other Gene Editing Technologies · and Viral Vector-mediated Transgenesis
By ApplicationBiomedical Research · Drug Discovery and Development · Toxicology and Safety Testing · Disease Modeling · Regenerative Medicine · Xenotransplantation · Biopharmaceutical Production · and Agricultural Trait Enhancement
By Disease AreaOncology · Neurological Disorders · Cardiovascular Diseases · Metabolic Disorders · Immunological and Autoimmune Diseases · Genetic and Rare Diseases · and Infectious Diseases
By End UserAcademic and Research Institutes · Pharmaceutical Companies · Biotechnology Companies · Contract Research Organizations (CROs) · Agricultural Research Organizations · and Government and Regulatory Laboratories
By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
Published In01 Apr 2026
Report CodeCMI9092
Pages250+
FormatsExcel and PDF
Base Year2025
Estimated Year2026
Historical Range2020 - 2024
Forecast Period2026-2033
Market Segmentation
Animal Type Insights (Revenue, USD Bn, 2021 - 2033)